49 Wealth Management’s ESSA Pharma EPIX Stock Holding History

49 Wealth Management’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-11,172	Closed	-$20K	–	197
2024 Q4	$20K	Buy	+11,172	New	+$35.6K	﹤0.01%	171

Other funds holding EPIX

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Aldebaran Capital Carmel, Indiana $133M AUM 42.18% 1-Year Est. Return

49 Wealth Management's EPIX Position: Q1 2025 in Review

49 Wealth Management sold out of ESSA Pharma (EPIX) in Q1 2025, closing a stake of 11,172 shares — an estimated $20K sold.

49 Wealth Management first reported a position in EPIX in Q4 2024 and held it in 1 quarter. The position peaked at $20K in Q4 2024. 36 funds tracked by Wall St. Rank hold EPIX as of Q1 2025.

49 Wealth Management reported no remaining ESSA Pharma position as of Q1 2025 after selling out during the quarter.
49 Wealth Management sold 11,172 ESSA Pharma shares in Q1 2025, an estimated $20K.
49 Wealth Management first reported a position in ESSA Pharma in Q4 2024 and held it in 1 quarter.
49 Wealth Management's ESSA Pharma position peaked at $20K in Q4 2024.
36 funds tracked by Wall St. Rank held ESSA Pharma as of Q1 2025.

Based on 49 Wealth Management's 13F filing for Q1 2025, filed 30 Apr 2025.